Related Experiment Videos
Unstable angina and thrombolysis
1Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston 02115.
Insights
Unstable angina patients with coronary thrombus may benefit from thrombolytic therapy. Large trials are investigating if tissue plasminogen activator (rt-PA) improves outcomes compared to conventional treatments.
Area of Science:
- Cardiology
- Thrombosis
- Interventional Cardiology
Background:
- Unstable angina (UA) affects diverse patient groups.
- Coronary artery thrombus is frequently observed in patients with rest angina and predicts adverse events like myocardial infarction and death.
- Small studies suggest thrombolytic therapy may resolve thrombus and improve outcomes in UA.
Purpose of the Study:
- To evaluate the efficacy of thrombolytic therapy, specifically recombinant tissue plasminogen activator (rt-PA), in patients with unstable angina and non-Q-wave infarction.
- To determine if rt-PA improves angiographically assessed coronary stenoses.
- To compare rt-PA with conventional therapy and assess the need for routine angiography and revascularization.
Main Methods:
- Large-scale, multicenter clinical trials were designed.
- Patients with unstable angina and non-Q-wave infarction were enrolled.
- Investigated the impact of rt-PA on coronary stenoses, clinical outcomes, and the necessity of subsequent interventions.
Main Results:
- Ongoing large multicenter trials aim to answer key questions regarding rt-PA efficacy.
- Results are pending to confirm if rt-PA improves coronary stenoses and clinical outcomes.
- The optimal role of rt-PA in unstable angina management requires further investigation.
Conclusions:
- The role of thrombolytic therapy, including rt-PA, in unstable angina remains speculative pending results from large clinical trials.
- Further research is needed to establish the benefits and optimal use of rt-PA in this patient population.
- The study highlights the need for evidence-based guidelines for thrombolytic therapy in unstable angina.
Abstract:
Unstable angina occurs in a heterogeneous population of patients. In the subset of patients with recent rest angina, both angiographic and angioscopic studies have suggested that coronary artery thrombus is often present and serves as a predictor of subsequent adverse clinical events, including recurrent angina, myocardial infarction, the need for urgent coronary revascularization, and death. Studies of thrombolytic therapy in small populations of patients with unstable angina suggest it may lyse coronary thrombus, raise the ischemic threshold, and possibly have a favorable influence on clinical outcome. Large multicenter trials of patients with unstable angina and non-Q-wave infarction have been designed to answer several questions: Will rt-PA produce improvement in angiographically determined coronary arterial stenoses? Is rt-PA superior to conventional therapy? Is there a need for routine angiography, followed by revascularization, in suitable patients? Until these questions are answered, the role of thrombolytic therapy in patients with unstable angina remains speculative.